Medicare Enrolled

Dr. Julibeth Alvarez, M.D.

Name: Federal CMS public records for Dr. Julibeth Alvarez (NPI 1891066973)
Creator: U.S. Centers for Medicare & Medicaid Services
License: https://www.usa.gov/government-works

Ophthalmology · Tamarac, FL

Low-engagement

6233 N UNIVERSITY DR, Tamarac, FL 33321

9547210000

In practice since 2012 (14 years)

NPI: 1891066973 verify on NPPES ↗

High

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Alvarez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Alvarez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alvarez

Dr. Julibeth Alvarez is an ophthalmology in Tamarac, FL, with 14 years in practice.

Between the years covered by Open Payments, Dr. Alvarez received a total of $4,922 from 24 pharmaceutical and/or device companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alvarez is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice$ $4,922 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$4,922

Total received (2018-2024)

Avg $703/year across 7 years

Top 26% in FL for ophthalmology

Companies

108

Individual payments

All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel

Food, beverages, travel, and lodging — typically low-value

$4,922 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$674

2023

$590

2022

$835

2021

$1,147

2020

$456

2019

$743

2018

$477

Payments by company (2024)

Consulting

Speaking

Meals & Travel

Research

Aerie Pharmaceuticals, Inc.

$891

Allergan, Inc.

$643

ABBVIE INC.

$389

Alcon Vision LLC

$344

Allergan Inc.

$298

Sun Pharmaceutical Industries Inc.

$296

Oyster Point Pharma, Inc.

$270

Bausch & Lomb Americas Inc.

$264

SUN PHARMACEUTICAL INDUSTRIES INC.

$262

Tarsus Pharmaceuticals, Inc.

$224

AbbVie Inc.

$200

Horizon Therapeutics plc

$173

Bausch & Lomb, a division of Bausch Health US, LLC

$147

Amgen Inc.

$122

TISSUETECH, INC.

$112

Johnson & Johnson Surgical Vision, Inc.

$103

Dompe US, Inc.

$39

BIOTISSUE HOLDINGS INC.

$38

Novartis Pharmaceuticals Corporation

$22

Glaukos Corporation

$22

Grifols USA, LLC

$21

Shire North American Group Inc

$16

TissueTech, Inc.

$16

Alimera Sciences, Inc.

$11

Top 3 companies account for 39.1% of total payments

Associated products mentioned in payments ›

AcrySof IQ PanOptix · BESIVANCE · BROMSITE · CEQUA · COMBIGAN · Catalys Laser System · Cequa · DURYSTA · ILUVIEN · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · LUMIGAN · MIEBO · OXERVATE · PROKERA · Prokera · Prolastin-C Liquid · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · Simbrinza · TEPEZZA · TYRVAYA · VUITY · VYZULTA · XDEMVY · XELPROS · XIIDRA · rhopressa · rocklatan

Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a ophthalmology in Tamarac?
Compare ophthalmologys in the Tamarac area by procedure volume, costs, and industry payment transparency.

Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi

235

Per 100K population

12.1

County median income

$74,534

Nearest hospital

UNIVERSITY HOSPITAL AND MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry	✓ NPPES	Weekly updates
Medicare Enrollment	✓ PECOS	Monthly updates
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not public	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Alvarez is a ophthalmology, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Alvarez receive payments from pharmaceutical companies?

Yes. Dr. Alvarez received a total of $4,922 from 24 companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently High for Dr. Alvarez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city

Ophthalmologys in Tamarac

Browse ophthalmologys in Tamarac ranked by procedure volume and transparency data.

Highest volume

Top Ophthalmologys in FL

Ophthalmologys ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Ophthalmologys in FL

Which FL ophthalmologys receive the most from drug and device companies.

By company

Aerie Pharmaceuticals, Inc. Payments to Doctors

See all physicians who received payments from Aerie Pharmaceuticals, Inc..

By company

Allergan, Inc. Payments to Doctors

See all physicians who received payments from Allergan, Inc..

By company

ABBVIE INC. Payments to Doctors

See all physicians who received payments from ABBVIE INC..

About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology